ReviewFrontiers in oncology2021

Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice.

Aurélien Corroyer-Dulmont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.